Lonza steps up probiotic presence with exclusive Organobalance agreement

By Andrew McDougall

- Last updated on GMT

Related tags Probiotic

Lonza has taken a big step into the probiotic market by announcing a worldwide exclusive licensing agreement with Organobalance, in which it will develop, produce and commercialize products containing a probiotic Lactobacillus strain.

“This agreement with Organobalance creates a basis for Lonza to enter the probiotic market - a market with vast growth potential - with a unique ingredient,”​ said Roman Quinter, senior vice president and head of Nutrition Ingredients business for Lonza.


“As the leader in the development of innovative probiotic strains, we regard this agreement with Lonza as a further recognition of Organobalance’s strategy, our expertise, and our innovative capacity,”​ said Prof. Dr. Christine Lang, CEO of Organobalance GmbH.

“We highly appreciate Lonza’s dedication to lead our development into great success on the nutrition marketplace,” ​she added.

Health benefits

Developed by Organobalance, the probiotic strain acts against Helicobacter pylori (H. pylori) which research shows has been implicated as a common cause of peptic ulcers and gastritis.

According to Steven Czinn in the Journal of Pediatrics​, about 50 per cent of the global population is infected with H. pylori. However, Lonza and Organobalance claim this new probiotic strain demonstrates great potential in helping to maintain a balanced H. pylori concentration.

They explain that utilizing a unique patent-protected mode of action, Lactobacillus anti-H. pylori binds to H. pylori in the stomach, thus creating large aggregates, which are subsequently flushed out of the stomach and excreted.

“Integrating the Lactobacillus Anti-H. pylori strain into our nutrition ingredient portfolio provides an opportunity to leverage our strong biotech expertise and knowledge to provide a highly effective product to the nutrition landscape,”​ explained Lonza’s Quinter.

Produced via a fermentation process, the Lactobacillus anti-H. pylori strain is patent-protected. The strain demonstrates probiotic activity by gently, yet highly effectively, removing H. pylori from the stomach.

Growing trend in cosmetics industry

Probiotics are bacteria found in the gut that are understood to have health benefits. Prebiotics are ingredients that stimulate growth of probiotics in the gut.

Probiotic and prebiotic products have mainly been used for food and pharmaceutical applications in the past, but they are also beginning to grab the attention of cosmetic manufacturers looking to tap the trend towards nutricosmetics products in recent years.

Related topics Business & Financial

Related news

Show more